Sorbus Advisors LLC

About
Services
Professionals
Resources
Blog
Contact

BioPharmaceutical Valuations in Purchase Accounting

November 20, 2015 | by Max Fonarev

Recent Posts

What M&A Purchase Consideration Is Actually Worth?
Covid-19 | Valuation Update | Three Months In
COVID-19 | Valuation Update
Valuing VC Investments – An Intuitive Example
Valuation Market Multiples: Not So Simple

Labels

Business Interests 409A Valuation Tax Valuation Life Sciences Financial Instruments Tax Compliance Intangible Asset Valuation IP Valuation Purchase Accounting Fair Value Financial Reporting Purchase Price Allocation Transactions ASC 805 Purchase Accounting Portfolio Valuation ASC 805 Fair Market Value Term Sheet

Twitter
Linkedin

© 2021 Sorbus Advisors LLC. All Rights Reserved. | Terms of Use | Privacy Policy

Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.

First Name*
Last Name*
Company
Newsletter Sign up*